Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial

NCT04744649 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Stomach Neoplasm

Interventions

DRUG: XELOX or SOX
DRUG: JS001+XELOX or SOX

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]